This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2025 (epidemiological weeks 10-13). Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2025 (epidemiological weeks 10-13). Click here to view PDF
Brucellosis, also known as undulant fever or Malta fever, is a zoonotic disease caused by the Brucella species. Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during February 2025 (epidemiological weeks 6-9). Click here to view PDF
The report aims to give insight into a specified diabetic population with identification of high-risk individuals who would benefit from focused management. Click here to view PDF
Preventing invasive cryptococcal disease through active screening for cryptococcal antigenemia in people living with advanced HIV. Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare Laboratories during January 2025 (epidemiological weeks 1-5). Click here to view PDF
Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women. It is characterised by a dysbiosis of the normal vaginal flora whereby a mixed bacterial flora including mixed anaerobes replaces the dominant lactobacilli. Click here to view PDF
Recent media reports raised concerns regarding an increase in human metapneumovirus (hMPV) cases in China. This document aims to provide a summary of the current respiratory infection season in China and provide a brief overview of hMPV. Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2024, with additional data from December 2024. Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during November 2024 (epidemiological weeks 45-48). Click here to view PDF